Metagenomi, Inc. Common StockMGXNASDAQ
Loading
Research and development spending
3Y CAGR
+29.2%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $93.11M | -14.7% |
| 2024 | $109.18M | +15.7% |
| 2023 | $94.40M | +118.8% |
| 2022 | $43.14M | +198.0% |
| 2021 | $14.48M | - |